Xcout Intel
Earli Inc. competitors & alternatives
The 12 closest competitors and alternatives to Earli Inc. among biotech companies — ranked by similarity to what Earli Inc. actually does, not by market-cap band.
Subscribe to see Earli Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Earli Inc.
Earli, Inc. is a U.S. biotechnology company developing synthetic-biology-based technologies for detecting and treating cancer. Its platform is designed to activate signals or therapeutic effects specifically within tumors, serving cancer patients and clinical researchers.
Earli Inc. at a glance
Earli Inc. is a biotech company headquartered in United States. Its most recent funding round, Series A, raised $40M in January 2021. Xcout tracks 3 named people at Earli Inc., including David Suhy (Chief Scientific Officer). Xcout recorded 2 job postings from Earli Inc. in the last 90 days.
Earli Inc. leadership
- David SuhyChief Scientific Officer
- Cyriac RoedingCo-founder
- Sam GambhirFounder
Earli Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $40M | 10 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Earli Inc.
Xcout recorded 2 job postings from Earli Inc. in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Earli Inc.'s hiring signals →
Top 12 Earli Inc. competitors
Ranked by semantic similarity — how close each company is to Earli Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotech company
General Biotechnologies develops programmable synthetic biology platforms that use edible microbes to manufacture and deliver peptide therapeutics. The company primarily serves the pharmaceutical industry by reformulating discontinued peptide drugs into low-cost, needle-free oral medications and providing field-deployable biomanufacturing kits.
Biotechnology
T3 Pharmaceuticals AG is a biotechnology company that develops a proprietary technology platform utilizing bacteria to deliver targeted therapies. The company focuses on advancing a pipeline of Immuno-Oncology products designed to treat cancer patients.
Similar biotech company
Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts.
Similar biotech company
Valerio Therapeutics is a biotechnology company that develops precision-guided therapeutics for complex and underserved diseases. It utilizes a proprietary V-Body conjugate platform, based on synthetic single-domain antibody libraries, to enable targeted drug delivery and deep tissue penetration.
Biotechnology
Serotiny is a synthetic biology company engineering multi-domain protein systems for cell therapies, including Chimeric Antigen Receptors (CARs). The firm operates within the biotechnology sector and has established biopharma technology agreements with partners like Twist Bioscience.
Biotechnology
76Bio, Inc. is a biotechnology company founded in 2020 and based in Boston, United States. The company develops therapeutics for patients with life-threatening diseases by pioneering targeted protein degraders.
Biotechnology
Biora Therapeutics is a U.S. biotechnology company developing ingestible, device-based platforms for delivering biologic medicines to targeted areas of the gastrointestinal tract and into systemic circulation. Its technologies are intended for use by pharmaceutical and biotechnology companies developing oral or targeted biologic therapies.
Biotechnology
Laigo Bio is a biotechnology company that develops targeted protein degradation therapeutics using its proprietary SureTAC platform. The company utilizes bispecific antibodies to direct cell surface targets toward lysosomal degradation, primarily serving the oncology and immunology sectors.
Biotechnology
Alixia, Inc. is a biotechnology company that develops therapeutics targeting tumor ecosystems to address cancer drug resistance and complex, chronic diseases. The company utilizes a research platform integrating biology, biophysics, computational chemistry, and clinical input to discover lead compounds that disrupt metabolic and inflammatory triggers within the tumor microenvironment.
Biotechnology
Reverb Therapeutics is a biotechnology research company headquartered in Vancouver, British Columbia. The company focuses on cancer therapeutics by developing its proprietary Amplify-R platform designed to intelligently adjust and tune the body's natural immune system.
Biotechnology
Parabilis Medicines is a biopharmaceutical company that develops ultra-tunable peptide therapeutics utilizing its proprietary Helicon platform. The company focuses on creating novel medicines to target historically undruggable conditions, primarily addressing cancer and other serious diseases with critical medical needs.
Similar biotech company
Werewolf Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing novel therapies that activate the body's immune system to combat cancer. Leveraging its exclusive PREDATOR platform, the company crafts conditionally activated molecules designed to stimulate both adaptive and innate immunity. This strategic approach aims to circumvent the shortcomings often associated with traditional proinflammatory immune treatments. Key among its product pipeline are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule targeting advanced solid tumors, and WTX-330, an Interleukin-12 INDUKINE molecule also designed for conditional activation, intended for advanced or metastatic solid tumors or lymphomas that have relapsed or are refractory. Furthermore, Werewolf Therapeutics is progressing WTX-613, a conditionally activated interferon alpha INDUKINE molecule, for addressing solid tumors and hematologic malignancies. The company was founded in 2017 and operates from its headquarters in Cambridge, Massachusetts.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Earli Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Earli Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →